Comparative effects of oncogenic mutations G12C, G12V, G13D, and Q61H on local conformations and dynamics of K-Ras
K-Ras is the most frequently mutated protein in human cancers. However, until very recently, its oncogenic mutants were viewed as undruggable. To develop inhibitors that directly target oncogenic K-Ras mutants, we need to understand both their mutant-specific and pan-mutant dynamics and conformation...
Main Authors: | Sezen Vatansever, Burak Erman, Zeynep H. Gümüş |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037019303563 |
Similar Items
-
In Silico Strategies for Designing of Peptide Inhibitors of Oncogenic K-Ras G12V Mutant: Inhibiting Cancer Growth and Proliferation
by: Mehreen Ghufran, et al.
Published: (2022-10-01) -
Ras Isoforms from Lab Benches to Lives—What Are We Missing and How Far Are We?
by: Arathi Nair, et al.
Published: (2021-06-01) -
K-RAS4A: Lead or Supporting Role in Cancer Biology?
by: Veronica Aran
Published: (2021-09-01) -
A saturation-mutagenesis analysis of the interplay between stability and activation in Ras
by: Frank Hidalgo, et al.
Published: (2022-03-01) -
KRAS (G12D) Cooperates with AML1/ETO to Initiate a Mouse Model Mimicking Human Acute Myeloid Leukemia
by: Shanmin Zhao, et al.
Published: (2014-01-01)